Merck and Co. (MRK.N: Quote, Profile, Research) Chief Executive Raymond Gilmartin on Tuesday said his company will push hard to co-market a new cholesterol drug with partner Schering-Plough even as it competes with Merck’s own popular $5 billion-a-year drug, Zocor.
